These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7946765)

  • 1. Optimising heart failure pharmacotherapy: the ideal combination.
    Cleland JG; Dutka DP
    Br Heart J; 1994 Aug; 72(2 Suppl):S73-9. PubMed ID: 7946765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of increased dose of diuretics on symptoms, weight, 6-minute walk distance, and echocardiographic measurements of left ventricular systolic and diastolic function in 51 patients with symptomatic heart failure caused by reduced left ventricular ejection fraction treated with beta blockers and angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
    Kumar A; Aronow WS; Vadnerkar A; Sivan K; Mittal S
    Am J Ther; 2009; 16(1):5-7. PubMed ID: 19142162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Euro heart failure survey. Medical treatment not in line with current guidelines.
    Drechsler K; Dietz R; Klein H; Wollert KC; Storp D; Molling J; Zeymer U; Niebauer J
    Z Kardiol; 2005 Aug; 94(8):510-5. PubMed ID: 16049652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors for 'diastolic' heart failure? reasons not to jump to premature conclusions about the efficacy of ACE inhibitors among older patients with heart failure.
    Cleland JG
    Eur J Heart Fail; 2001 Dec; 3(6):637-9. PubMed ID: 11738214
    [No Abstract]   [Full Text] [Related]  

  • 5. Physiological rationale for co-treatment with diuretics in heart failure.
    Cohn JN
    Br Heart J; 1994 Aug; 72(2 Suppl):S63-7. PubMed ID: 7946763
    [No Abstract]   [Full Text] [Related]  

  • 6. Left ventricular diastolic heart failure with normal left ventricular systolic function in older persons.
    Aronow WS
    J Lab Clin Med; 2001 May; 137(5):316-23. PubMed ID: 11329528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
    Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From left ventricular dysfunction to heart failure.
    Cleland JG
    Arch Mal Coeur Vaiss; 1996 Nov; 89(11):1397-402. PubMed ID: 9092398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K
    Am J Cardiovasc Drugs; 2002; 2(1):1-6. PubMed ID: 14727993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex-related differences in the use and adverse effects of angiotensin-converting enzyme inhibitors in heart failure: the study of patients intolerant of converting enzyme inhibitors registry.
    Shah MR; Granger CB; Bart BA; McMurray JJ; Petrie MC; Michelson EL; Tudor GE; Swedberg K; Stevenson LW; Califf RM; Pfeffer MA
    Am J Med; 2000 Oct; 109(6):489-92. PubMed ID: 11042239
    [No Abstract]   [Full Text] [Related]  

  • 11. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey.
    Lainscak M; Cleland JG; Lenzen MJ; Follath F; Komajda M; Swedberg K
    Eur J Heart Fail; 2007 Mar; 9(3):292-9. PubMed ID: 17023204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure secondary to left ventricular systolic dysfunction. Therapeutic advances and treatment recommendations.
    Dracup K
    Nurse Pract; 1996 Sep; 21(9):56-8, 61, 65-8. PubMed ID: 8884795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient management of congestive heart failure.
    Massin EK
    Tex Heart Inst J; 1998; 25(4):238-50. PubMed ID: 9885099
    [No Abstract]   [Full Text] [Related]  

  • 14. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
    van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diastolic heart failure and left ventricular diastolic dysfunction: what we know, and what we don't know!
    Shammas RL; Khan NU; Nekkanti R; Movahed A
    Int J Cardiol; 2007 Feb; 115(3):284-92. PubMed ID: 16904774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin and angiotensin converting enzyme inhibitors in chronic heart failure.
    Gheorghiade M
    Can J Cardiol; 1990 Aug; 6 Suppl C():14C-17C. PubMed ID: 2205342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diastolic cardiac insufficiency].
    Spoto S; Palma Modoni A; De Galasso L
    Clin Ter; 2002; 153(5):355-7. PubMed ID: 12510423
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of adding torasemide to standard therapy on peak oxygen consumption, natriuretic peptides, and quality of life in patients with compensated left ventricular systolic dysfunction.
    Gupta S; Waywell C; Gandhi N; Clayton N; Keevil B; Clark AL; Ng LL; Brooks N; Neyses L
    Eur J Heart Fail; 2010 Jul; 12(7):746-52. PubMed ID: 20525705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics].
    Komajda M
    Arch Mal Coeur Vaiss; 2000 Feb; 93 Spec No 2():13-6. PubMed ID: 10830083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.